Delivery Order SPE2DB22D1106-SPE2DB25FEWA4

Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 0.25 mg tablets. The contract has a ceiling value of $1,295.79 and a completion date of November 27, 2024. It is a firm-fixed-price contract, which indicates the price is set and not subject to adjustment. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,851.29, is for the delivery of RISPERIDONE 0.25 MG TABLET 500S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide RISPERIDONE 0.5 MG TABLET 60S. The contract has a ceiling value of $1,286.23 and a performance period ending on June 12, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Risperidone 0.5 mg tablets. The order is valued at $1,599.44 and has a completion date of August 13, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the government to efficiently procure a comprehensive...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERIDONE 2 MG TABLET 60S, a prescription medication, with a ceiling value of $1,290.51 and a completion date of May 22, 2025. The contract is a Firm Fixed Price arrangement and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERIDONE 0.5 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price of $1,260.51 and a period of performance through June 16, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of RISPERIDONE 3 MG TABLET 60S. The contract has a ceiling value of $5,401.99 and is a firm fixed price delivery order, with a period of performance through June 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,807.96 firm fixed-price contract is for the delivery of RISPERIDONE 1 MG TABLET 500S, a medication used to treat certain mental/mood disorders. The contract has an ultimate completion date of June 9, 2025 and is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Risperidone 1 mg orally disintegrating tablets in 30-count units, with a potential value of $1,291.08 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.85 fixed-price contract is for the delivery of 500 tablets of 0.25 mg Risperidone, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of May 13, 2024 and was awarded on May 10, 2024. This delivery order is part of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEWA4
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERIDONE 0.25 MG TABLET 500S, a medication, with a ceiling value of $2,384.30 and a performance period ending on July 3, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely placed against that larger IDC contract. The contract is not designated as a set-aside, indicating open competition.

Generated 10/1/25, 9:46 AM